Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 8/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3920906 | 1.00 | SIGMAR1 (0.47) | SIGMAR1HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL10454474 | 0.89 | SIGMAR1 (0.41) | SIGMAR1HDAC3MAPK1ADRA1AHDAC4 | |
| SCHEMBL2242691 | 0.88 | GPR52 (0.52) | GPR52 | |
| SCHEMBL2242689 | 0.88 | GPR52 (0.52) | GPR52 | |
| SCHEMBL27637213 | 0.83 | KCNH2 (0.47) | SIGMAR1 | |
| SCHEMBL27553647 | 0.81 | KCNH2 (0.50) | SIGMAR1 | |
| SCHEMBL27665858 | 0.81 | HDAC3 (0.41) | HDAC3HDAC4HDAC1HDAC7HDAC2 | |
| SCHEMBL11197172 | 0.81 | CYP2A6 (0.41) | GPR52 | |
| Phenylethyl Alcohol SCHEMBL27980778 | 0.80 | TDP1 (0.48) | SIGMAR1HDAC3SMN1; SMN2 | |
| SCHEMBL95321 | 0.79 | HDAC3 (0.47) | SIGMAR1HDAC3MAPK1ADRA1AHDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1888502-B1 | CATALYTIC SCRIABINE REACTION | FIRMENICH & CIE (CH) | 2016-07-13 | — | — | EP | disclosed |
| US-7524983-B2 | Catalytic scriabine reaction | FIRMENICH SA (CH) | 2009-04-28 | — | — | US | disclosed |
| US-20080091042-A1 | CATALYTIC SCRIABINE REACTION | FIRMENICH SA (CH) | 2008-04-17 | — | — | US | disclosed |
| EP-1888502-A2 | CATALYTIC SCRIABINE REACTION | FIRMENICH SA (CH) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006120639-A2 | CATALYTIC SCRIABINE REACTION | FIRMENICH SA (CH) | 2006-11-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080091042-A1 | CATALYTIC SCRIABINE REACTION | AMY1A, MAN2B2, SLC5A1 | SIGMAR1 438/4885HDAC3 283/4885MAPK1 212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.